T‐Cell Immunotherapy of Tumors by Adoptive Transfer of Cytotoxic T Lymphocytes and by Vaccination with Minimal Essential Epitopes

This publication has 40 references indexed in Scilit:

• Detailed motifs for peptide binding to HLA-A∗0201 derived from large random sets of peptides using a cellular binding assay
  Human Immunology, 1995
• Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity
  Molecular Immunology, 1994
• Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
  Immunity, 1994
• Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
  European Journal of Immunology, 1993
• In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53
  European Journal of Immunology, 1993
• Strict peptide length is not required for the induction of cytotoxic T lymphocyte‐mediated antiviral protection by peptide vaccination
  European Journal of Immunology, 1993
• Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
  Nature, 1993
• Human papillomaviruses in the pathogenesis of anogenital cancer
  Virology, 1991
• Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
  Nature, 1991
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988